Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for L-Alanyl-L-Glutamine.
A stable dipeptide that enhances electrolyte and water absorption across the intestinal lumen while supporting muscle protein synthesis and immune function during physiological stress.
95977
176.24 g/mol
2.2
5-phenyl-1H-imidazole-2-thiol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for L-Alanyl-L-Glutamine across standard consumer modalities.
The high hygroscopicity of the dipeptide requires moisture-resistant HPMC capsules to prevent clumping and degradation over shelf-life.
The high dosage requirements typically exceeding 500mg pose significant challenges for pectin matrix integrity, often resulting in a rubbery or unstable texture.
The substantial therapeutic dose exceeds the typical 50mg payload capacity of thin-film polymers, making it physically unsuitable for standard oral strip delivery.
Ready to launch a product featuring L-Alanyl-L-Glutamine? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your L-Alanyl-L-Glutamine extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your L-Alanyl-L-Glutamine payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation